As antimicrobial resistance (AMR) continues to pose a severe threat to global public health, Nigerian microbiologist Bridget Ugochi Anyanwueze, a researcher in the Department of Biology at Southeast Missouri State University in Cape Girardeau, Missouri, has developed an improved in vitro laboratory methodology aimed at enhancing how scientists evaluate and characterize new antimicrobial compounds.
​The breakthrough, highlighted in media reports on Friday, November 13, 2026, builds on Anyanwueze’s peer-reviewed study titled “An Improved in vitro Method for Quantifying the Kinetics of Bacterial Inhibition-Zone Development,” published on June 27, 2026, in the IPS Journal of Applied Microbiology and Biotechnology (Vol. 6, No. 2).
​Traditional disc diffusion assays—one of the most widely used laboratory techniques for testing bacterial susceptibility—typically rely on a single endpoint measurement of the “zone of inhibition,” the clear area around an antibiotic disc where bacteria cannot grow. Anyanwueze’s method replaces that static snapshot with a time-dependent approach that tracks and quantifies the kinetics of inhibition-zone formation and expansion across multiple intervals during incubation.
​In her laboratory investigations conducted at Southeast Missouri State University, Anyanwueze evaluated the inhibition-zone expansion produced by standard antibiotics—including ampicillin, erythromycin, and neomycin, against Staphylococcus epidermidis over an incubation window spanning from 4 hours to 25 hours.
Statistical analyses of the experimental data revealed significant effects driven by antibiotic type, incubation time, and their interaction, demonstrating that different antimicrobial agents exhibit distinct inhibition-zone expansion rates over time.
By capturing dynamic bacterial inhibition rather than relying solely on a final static reading, the method provides deeper insights into how compounds diffuse and suppress microbial growth, offering researchers a vital complementary tool for screening novel therapeutic candidates.
​Anyanwueze’s methodological innovation also complements parallel investigations into plant-derived antimicrobial compounds. Earlier in 2026, in studies published in April 2026 in the International Journal of Current Microbiology and Applied Sciences and on May 28, 2026.
In the Journal of Phytochemistry, Ethnobotany and Traditional Medicine Systems, she evaluated the antibacterial and antifungal properties of Moringa oleifera and Azadirachta indica (neem) leaf extracts against microbial isolates in Cape Girardeau, identifying bioactive phytochemicals capable of inhibiting pathogenic growth.
​The scientific milestone arrives just weeks before Nigeria makes history as the first African nation to host the 5th Global High-Level Ministerial Conference on Antimicrobial Resistance, scheduled for December 6 to 8, 2026, in Abuja.
Speaking ahead of the global summit during ministerial preparations in Abuja, Sen. Dr. Aliyu Sabi Abdullahi, Minister of State for Agriculture and Food Security, emphasized the urgency of translating scientific research and policy commitments into measurable actions across human health, agriculture, and the environment.
​By establishing a foundation for measuring time-dependent bacterial inhibition, Anyanwueze’s work equips microbiologists and pharmaceutical researchers with a more nuanced diagnostic framework to accelerate the discovery and validation of next-generation antimicrobial agents.
